# China NMPA Inspection - Guangzhou Micropeptide Biotechnology Co., Ltd. - October 19, 2020

Source: https://www.globalkeysolutions.net/records/china_inspection/guangzhou-micropeptide-biotechnology-co-ltd/675ece67-954f-4e57-b0b3-1001a5291fe5/
Source feed: China

> China NMPA unannounced inspection for Guangzhou Micropeptide Biotechnology Co., Ltd. published October 19, 2020. The National Medical Products Administration (NMPA) conducted an unannounced inspection of Guangzhou Weitai Biotechnology Co., Ltd. prior to October 1

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Announcement No. 70 of 2020 from the National Medical Products Administration regarding the suspension of production and rectification of Guangzhou Micropeptide Biotechnology Co., Ltd.
- Company Name: Guangzhou Micropeptide Biotechnology Co., Ltd.
- Publication Date: 2020-10-19
- Product Type: cosmetics
- Summary: The National Medical Products Administration (NMPA) conducted an unannounced inspection of Guangzhou Weitai Biotechnology Co., Ltd. prior to October 12, 2020, with findings announced on October 19, 2020. The inspection revealed serious violations of the "Cosmetics Production Licensing Work Specifications," highlighting significant deficiencies across the company's operations. 

Key issues included a lack of raw material inspection and inventory records, failure to implement a material release system, and missing batch production records for finished goods. Facility problems encompassed an unsuitably designed clean production workshop that risked product contamination, undefined material and personnel flow, and disorganized warehousing with improperly stored raw materials. Equipment failures involved missing status indicators on machinery and irregular replacement of air filters. Furthermore, unregistered finished products were found, along with raw materials inconsistent with registered formulas, improperly stored materials, and inadequate finished product sampling. Production management deficiencies included incomplete production records and insufficient site cleaning after operations. 

As a result, the NMPA has ordered the Guangdong Provincial Drug Administration to mandate an immediate suspension of all cosmetic production by Guangzhou Weitai Biotechnology Co., Ltd. The company is required to undertake comprehensive rectification and successfully pass a follow-up inspection before resuming production. Any discovery of further illegal activities will lead to severe legal penalties.

Company: https://www.globalkeysolutions.net/companies/guangzhou-micropeptide-biotechnology-co-ltd/c6753b63-8dec-4d94-b4eb-76742aff5583/